KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Non-Current Liabilities (2016 - 2026)

AbbVie has reported Total Non-Current Liabilities over the past 14 years, most recently at $104.7 billion for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 2.94% to $104.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $104.7 billion through Dec 2025, up 2.94% year-over-year, with the annual reading at $104.7 billion for FY2025, 2.94% up from the prior year.
  • Total Non-Current Liabilities was $104.7 billion for Q4 2025 at AbbVie, roughly flat from $104.9 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $124.2 billion in Q1 2021 and troughed at $101.7 billion in Q4 2024.
  • The 5-year median for Total Non-Current Liabilities is $108.1 billion (2022), against an average of $110.5 billion.
  • Year-over-year, Total Non-Current Liabilities soared 36.15% in 2021 and then decreased 14.22% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $116.2 billion in 2021, then decreased by 9.53% to $105.1 billion in 2022, then dropped by 0.68% to $104.4 billion in 2023, then dropped by 2.64% to $101.7 billion in 2024, then rose by 2.94% to $104.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Total Non-Current Liabilities are $104.7 billion (Q4 2025), $104.9 billion (Q3 2025), and $105.3 billion (Q2 2025).